Dr Siva Sanker Reddy Lingareddygari
Professor
Santhiram College of Pharmacy, Nandyal
Expertise:
Medicinal Chemistry
10
Publications
0
Projects
1
Scopus Citations
30
CrossRef
21 Years 1 Month Total Experience
Scopus
1
Citations
1
h-index
CrossRef
30
Citations
4
h-index
Google Scholar
Loading Scholar statistics...
Professional Recognition
No Data Found
There is currently nothing to display here.
Community & Membership
No Data Found
There is currently nothing to display here.
IPA
PERMANENTAPTI
PERMANENTPersonal Details
Doctor of Philosophy
2016
N/A
Master of Arts
2005
Shimane University, Matsue, Japan
Master of Arts
2002
N/A
Professor
Jul 2017 – Present
Santhiram College of Pharmacy, Nandyal
Associate Professor
Oct 2006 – Jul 2017
Creative Educational Society's College of Pharmacy, Kurnool
Assistant Professor
Aug 2005 – Oct 2006
Safa College of Pharmacy, Kurnool
Medical and Health Sciences
Scholarly Work
No Data Found
There is currently nothing to display here.
No Data Found
There is currently nothing to display here.
INDEN-1-YLIDENE GROUP CONTAINING HYDRAZINE BASED COMPOUNDS, COMPOSITIONS, METHODS OF MAKING AND USIN
SIVA SANKER REDDY LINGAREDDYGARI
-
Application No. :
201941014888
Filed :
12-04-2019
Published :
16-10-2020
Filed
DIAZENYL GROUP CONTAINING CHALCONES AND COMPOSITIONS AND METHODS OF MAKING AND USING THE SAME
SIVA SANKER REDDY LINGAREDDYGARI
-
Application No. :
201641026047 A
Filed :
29-07-2016
Published :
02-02-2018
Filed
Scholarly Publications
Development and Validation of UV-Spectrophotometric Techniques Using Zero-order, Derivative, and AUC Approaches to Determine Dapagliflozin in Plasma
Open AccessAnalytical Method Development and Validation of Quetiapine Fumarate in API and Dosage form by Using RP–HPLC
Open AccessDesign of Experiment Approach for Method Development and Validation of Bilastine in Pure and Pharmaceutical Dosage form using RP-UFLC
Open Access
10.13005/ojc/390325
Crossref: 5
Repurposing Thalidomide, its Analogue and Apremilast for Possible Antiviral in Situation of Severe COVID Cytokine Syndrome
STABILITY INDICATING METHOD DEVELOPMENT AND VALIDATION OF FEXOFENADINE HYDROCHLORIDE IN BULK AND ITS PHARMACEUTICAL DOSAGE FORM BY USING RP-HPLC
A new cerebral ischemic injury model in rats, preventive effect of gallic acid and in silico approaches
Open Access
10.1016/j.sjbs.2021.05.044
Crossref: 11
Method Development and Validation for Estimation of related Substances in Tilorone Dihydrochloride using RP¬-HPLC
10.52711/0974-360x.2021.00577
Crossref: 1
Analytical Method Development and Stability Studies for Estimation of Oseltamivir In Bulk and Capsules Using RPHPLC
Showing 1 to 8 of 10 publications